Kittai AS, Skarbnik A, Miranda M, Yong ASM, et al. A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia. Am J Hematol 2023 Oct 9. doi: 10.1002/ajh.27110.
PMID: 37811799